๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
In this i-SABR (immunotherapy + Stereotactic Ablative Body Radiation) trial...
Status
Completed
Location
University of Texas Southwestern Medical Center
Start Date
2013-10-02
Trial ID
NCT01896271
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and toxicity of tande...
Status
Unknown
Location
Multiple Locations
Start Date
2009-01-01
Trial ID
NCT03061656
Treatments Being Tested
The purpose of this study is to improve outcome of high risk neuroblastoma ...
Status
Unknown
Location
Samsung Medical Center
Start Date
2015-04
Trial ID
NCT02771743
This is a Phase 2 study designed to evaluate the combination of checkpoint ...
Status
Completed
Location
University of Minnesota Masonic Cancer Center
Start Date
2019-05-28
Trial ID
NCT03850691
RATIONALE: Giving chemotherapy, natural killer cells, aldesleukin, and tota...
Status
Terminated
Location
Masonic Cancer Center at University of Minnesota
Start Date
2006-02
Trial ID
NCT00354172
Single center, open-label Proof of Principle phase II trial to assess objec...
Status
Withdrawn
Location
UO Immunoterapia e Laboratorio TCS, IRCCS IRST
Start Date
2016-03
Trial ID
NCT03226236
Treatments Being Tested
The patient's have neuroblastoma that has come back, or not gone away. The ...
Status
Completed
Location
Houston Methodist Hospital
Start Date
1997-12
Trial ID
NCT01713439
Treatments Being Tested
This is a phase II multi-institutional therapeutic study of NK-cell based n...
Status
Completed
Location
Emory University
Start Date
2011-09
Trial ID
NCT01370213
Purpose of this Pilot Study: The investigators want to study the safety, si...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2012-10-09
Trial ID
NCT01701674
Background: A new cancer therapy takes white blood cells from a person, gr...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2019-05-16
Trial ID
NCT03745326